Return to: Healthcare NewsResearch and Clinical Trials Are Needed for the Advancement of Ibogaine TreatmentNassau, Bahamas – June 2025 – Oceanside Treatment Center, a leading clinical facility in Nassau, Bahamas, is calling for increased research and clinical trials to explore the potential of ibogaine as a treatment for substance use disorders, PTSD, depression, and anxiety. Understanding Ibogaine Ibogaine, a powerful plant-derived compound extracted from the root bark of the Tabernanthe iboga shrub native to West Africa, is drawing global attention for its transformative healing properties. Traditionally used in indigenous spiritual rituals, this naturally occurring psychoactive substance is now at the forefront of groundbreaking treatments for addiction and mental health. Research and anecdotal evidence suggest ibogaine treatment interrupts addictive patterns, reset neurological pathways, and offer profound relief from conditions such as PTSD, depression, and anxiety. Mechanism of Action Research suggests that ibogaine promotes neuroplasticity—the brain's ability to reorganize itself by forming new neural connections. This process can help individuals break free from entrenched patterns of addiction, reduce cravings, and ease withdrawal symptoms, often in a single treatment session. Additionally, ibogaine may modulate neurotransmitter systems involved in mood regulation, offering relief from depression and anxiety. Challenges in the United States In the United States, ibogaine is classified as a Schedule I controlled substance, making it illegal for medical use. This status has created significant barriers to conducting clinical trials and obtaining FDA approval. Despite promising anecdotal evidence and preliminary studies, such as those involving veterans with PTSD, the path to formal approval remains complex and costly. States like Texas, Kentucky, and California have initiated efforts to study ibogaine's efficacy, but progress is slow and often hindered by regulatory hurdles. chron.com International Treatment Centers Due to its legal status in the U.S., individuals seeking ibogaine treatment often turn to international centers located in the Bahamas. This facility operates under varying legal frameworks and has developed its own protocols to ensure safety and efficacy. At Oceanside Treatment Center, we adhere to high standards of care, employing experienced medical staff and integrating comprehensive support systems to maximize treatment outcomes. Our in-house research and data collection contributes to the growing body of knowledge on ibogaine's therapeutic potential. Recent Developments in Texas In a significant move, Texas has approved Senate Bill 2308 to establish a state-backed consortium for ibogaine research. This initiative aims to conduct FDA-approved clinical trials with a $50 million investment from the state's general fund. The consortium will include a university, hospital, and drug developer, positioning Texas as a leader in psychedelic-assisted mental health therapy. chron.com The Fentanyl Crisis The urgency for alternative treatments is underscored by the ongoing opioid epidemic. In 2024, nearly 108,000 Americans died from drug overdoses, with synthetic opioids like fentanyl accounting for approximately 90% of these deaths. The crisis has devastated communities, with fentanyl responsible for 81% of overdose-related deaths among individuals under 24. cdc.gov+1en.wikipedia.org+1thenationalnews.com Conclusion The need for effective treatments is critical. While ibogaine shows promise, further research and clinical trials are essential to fully understand its potential and integrate it into mainstream medical practice. Oceanside Treatment Center, Bahamas remains committed to advancing this field through our in-house research and compassionate care, offering hope to those affected by addiction and mental health disorders. For more information or to schedule a consultation, please contact: Name: Oceanside Treatment Center Phone: 1-800-386-0038 Email: bahamasoceanside@gmail.com OR Intakeoceanside@gmail.com Website: www.oceansideibogaine.com Note: This press release is for informational purposes only and does not constitute medical adv ... News Release: Research and Clinical Trials Are Needed for the Advancement of Ibogaine Treatment Submitted on: June 19, 2025 05:39:15 AM Submitted by: Oceanside Ibogaine On behalf of: oceansideibogaine.com |